Catalyst Biosciences Inc. (CBIO) Fundamentals

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.
SHARE INFORMATION
Market Cap$ 57,256,239
Shares Outstanding30,782,924
Float31,235,646
Percent Float101.47%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 7,338,000
Latest Fiscal EPS$ -2.87
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions129
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months368,871
Institutional Holdings Percent39.2%
Institutional Sold Previous 3 Months5,563,323
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent1.7
Insider Sold Previous 3 Months-
Insider Shares Owned531,535
TRADING INFO
52 Week High$ 5.20
52 Week Low$ 0.35
52 Week High Change$ -55.61
21 Day Moving Average$ 1.7914
21 Day Extended Moving Average$ 1.7839
50 Day Moving Average$ 1.6306
50 Day Extended Moving Average$ 1.5852
200 Day Moving Average$ 1.1438
200 Day Extended Moving Average$ 1.6739
10 Day Average Volume340,799
20 Day Average Volume337,642
30 Day Average Volume527,425
50 Day Average Volume1,427,693
Alpha0.016888
Beta1.4231
Standard Deviation0.338392
R20.044246
7 Day Price Change$ 0.02
7 Day Percent Change1.09%
21 Day Price Change$ 0.09
21 Day Percent Change5.08%
30 Day Price Change$ 0.10
30 Day Percent Change5.68%
Month to Date Price Change$ 0.11
Month to Date Percent Change6.29%
Quarter to Date Price Change$ 0.08
Quarter to Date Percent Change4.49%
180 Day Price Change$ 1.34
180 Day Percent Change256.73%
200 Day Price Change$ 1.22
200 Day Percent Change190.63%
Year to Date Price Change$ 0.946
Year to Date Percent Change103.5%

Catalyst Biosciences Inc. (CBIO) Key Ratios

PROFITABILITY
EBIT Margin-1,202.7%
EBITDA Margin-1,197.3%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin-0.5%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 5,533,000
Revenue Per Share$ 0.1797
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.20
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio2.80
Leverage Ratio1.40
Quick Ratio2.70
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ 25,324,548
Price to Sales10.3481
Price to Free Cash-1.10
PE High Last 5 Years-0.90
Price To Book2.20
Price To Cash Flow0.00
PE Low Last 5 Years-1.70
Price to Tangible Book2.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.10
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-104.81
Return on Equity-127.67
Return on Capital-118.98

Catalyst Biosciences Inc. (CBIO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorEisnerAmper LLP
CEONassim Usman
Emplyoees45
Last AuditUQ
CIK0001124105
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address611 Gateway Boulevard
Suite 710
South San Francisco, CA 94080
Websitehttps://www.catalystbiosciences.com
Facsimile-
Telephone+1 650 871-0761
Emailinvestors@catbio.com


Your Recent History
NASDAQ
CBIO
Catalyst B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.